Omega 3 FA May Improve Hypertension in CKD

A new study from Australia published in the Journal of Hypertension suggests omega 3 fatty acid supplementation may lead to a decrease in blood pressure as well as a reduction in cardiovascular disease in non-diabetics with moderate to severe chronic kidney disease.

In a double-blind, placebo-controlled intervention, 85 patients (74 completed the study) were randomized to either 4 grams of omega 3FA, 200mg Coenzyme Q10, both, or control for 8 weeks.

The study showed that omega 3FA use led to a reduction in blood pressure (-3.3 /- 2.9 +/- 0.7/0.5) , heart rate (-4 +/- 0.5 bpm) and triglycerides (-24%) in patients with CKD. CoQ use caused an increase in heart rate and no change in blood pressure.